Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

Trial Profile

Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Safinamide (Primary) ; Ketoconazole
  • Indications Alzheimer's disease; Drug-induced dyskinesia; Epilepsy; Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Merck KGaA; Merck Serono
  • Most Recent Events

    • 25 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top